Effect of sex and obesity on basal VLDL-triacylglycerol kinetics

American Journal of Clinical Nutrition

Volumn 77, Issue 3, 2003, Pages 573-579

  Mittendorfer, Bettina ^a   Patterson, Bruce W ^a   Klein, Samuel ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fatty acid; Kinetics; Lipolysis; Mathematical modeling; Stable isotopes; VLDL triacylglycerol

Indexed keywords

GLUCOSE; INSULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN EXPERIMENT; KINETICS; LEAN BODY WEIGHT; LIPID METABOLISM; MALE; OBESITY; SEX; STATISTICAL ANALYSIS;

EID: 0037369607     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/77.3.573     Document Type: Article

References (39)

1. Cryer A. Tissue lipoprotein lipase activity and its action in lipoprotein metabolism. Int J Biochem 1981;13:525-41.
2. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease - the Framingham Heart Study. Can J Cardiol 1988;4(suppl):5A-10A.
3. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 2000;86:943-9.
4. Lamon-Fava S, Wilson PW, Schaefer EJ. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1996;16:1509-15.
5. Austin MA. Plasma triglyceride as a risk factor for cardiovascular disease. Can J Cardiol 1998;14(suppl):14B-17B.
6. Cambien F, Jacqueson A, Richard JL, Warner JM, Ducimetiere P, Claude JR. Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study. Am J Epidemiol 1986;124:624-32.
7. Dullaart RP, Sluiter WJ, Dikkeschei LD, Hoogenberg, K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994;24:188-94.
8. Packard CJ, Demant T, Stewart JP, et al. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res 2000;41:305-18.
9. Blum CB. Dynamics of apolipoprotein E metabolism in humans. J Lipid Res 1982:23:1308-16.
10. Lewis GF. Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol 1997;8:146-56.
11. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989;83:1168-73.
12. Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G, Klein S. Effect of short-term fasting on lipid kinetics in lean and obese women. Am J Physiol 1999;276:E278-84.
13. Mittendorfer B, Horowitz JF, Klein S. Gender differences in lipid and glucose kinetics during short-term fasting. Am J Physiol 2001;281:E1333-9.
14. Kesaniemi YA, Beltz WF, Grundy SM. Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease. J Clin Invest 1985:76:586-95.
15. Grundy SM, Mok HY, Zech L, Steinberg D, Berman M. Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia. J Clin Invest 1979;63:1274-83.
16. Reaven GM, Bernstein RM. Effect of obesity on the relationship between very low density lipoprotein production rate and plasma triglyceride concentration in normal and hypertriglyceridemic subjects. Metabolism 1978;27:1047-54.
17. Nikkila EA, Kekki M. Polymorphism of plasma triglyceride kinetics in normal human adult subjects. Acta Med Scand 1971;190:49-59.
18. Patterson BW, Mittendorfer B, Elias N, Satyanarayana R, Klein S. Use of stable isotopically labeled tracers to measure very low density lipoprotein triglyceride turnover. J Lipid Res 2002;43:223-33.
19. Metropolitan Life Insurance Company. 1983 Metropolitan height and weight tables. Stat Bull Metrop Life Found 1983;64:3-9.
20. Converse CA, Skinner ER. Lipoprotein analysis: a practical approach. New York: Oxford University Press, 1992.
21. Hales CN, Randle PJ. Immunoassay of insulin with insulin antibody precipitate. Biochem J 1963;88:137-46.
22. McDonald-Gibson RG, Young M. The use of an automatic solids injection system for quantitative determination of plasma long-chain non-esterified fatty acids by gas-lipid chromatography. Clin Chim Acta 1974;53:117-26.
23. Boer P. Estimated lean body mass as an index for normalization of body fluid volumes in humans. Am J Physiol 1984;247:F632-6.
24. Reichl D. Lipoproteins of human peripheral lymph. Eur Heart J 1990;11(suppl):230-6.
25. Parks EJ, Krauss RM, Christiansen MP, Neese RA, Hellerstein MK. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J Clin Invest 1999;104:1087-96.
26. Sidossis LS, Mittendorfer B, Walser E, Chinkes D, Wolfe RR. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am J Physiol 1998;275:E798-805.
27. Barter PJ, Nestel PJ. Precursors of plasma triglyceride fatty acids in obesity. Metabolism 1973;22:779-83.
28. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995;95:158-66.
29. Seidell JC, Oosterlee A, Deurenberg P, Hautvast JG, Ruijs JH. Abdominal fat depots measured with computed tomography: effects of degree of obesity, sex, and age. Eur J Clin Nutr 1988;42:805-15.
30. Kamel EG, McNeill G, Van Wijk MC. Usefulness of anthropometry and DXA in predicting intra-abdominal fat in obese men and women. Obes Res 2000;8:36-42.
31. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 1995;27:435-8.
32. Lewis GF, Uffelman KD, Szeto LW, Steiner G. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 1993;42:833-42.
33. Howard BV, Zech L, Davis M, et al. Studies of very low density lipoprotein triglyceride metabolism in an obese population with low plasma lipids: lack of influence of body weight or plasma insulin. J Lipid Res 1980;21:1032-41.
34. Egusa G, Beltz WF, Grundy SM, Howard BV. Influence of obesity on the metabolism of apolipoprotein B in humans. J Clin Invest 1985;76:596-603.
35. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 1999;13:2051-60.
36. Arner P, Lithell H, Wahrenberg H, Bronnegard M. Expression of lipoprotein lipase in different human subcutaneous adipose tissue regions. J Lipid Res 1991;32:423-9.
37. St-Amand J, Despres JP, Lemieux S, et al. Does lipoprotein or hepatic lipase activity explain the protective lipoprotein profile of premenopausal women? Metabolism 1995;44:491-8.
38. Berman DM, Rogus EM, Busby-Whitehead MJ, Katzel LI, Goldberg AP. Predictors of adipose tissue lipoprotein lipase in middle-aged and older men: relationship to leptin and obesity, but not cardiovascular fitness. Metabolism 1999;48:183-9.
39. Yost TJ, Eckel RH. Regional similarities in the metabolic regulation of adipose tissue lipoprotein lipase. Metabolism 1992;41:33-6.